| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| BAK1 | BBC3 | ENSP00000363591 | ENSP00000404503 | Bcl-2 homologous antagonist/killer; Plays a role in the mitochondrial apoptosic process. Upon arrival of cell death signals, promotes mitochondrial outer membrane (MOM) permeabilization by oligomerizing to form pores within the MOM. This releases apoptogenic factors into the cytosol, including cytochrome c, promoting the activation of caspase 9 which in turn processes and activates the effector caspases. | Bcl-2-binding component 3, isoforms 3/4; [Isoform 3]: Does not affect cell growth. | 0.827 |
| BAK1 | BID | ENSP00000363591 | ENSP00000318822 | Bcl-2 homologous antagonist/killer; Plays a role in the mitochondrial apoptosic process. Upon arrival of cell death signals, promotes mitochondrial outer membrane (MOM) permeabilization by oligomerizing to form pores within the MOM. This releases apoptogenic factors into the cytosol, including cytochrome c, promoting the activation of caspase 9 which in turn processes and activates the effector caspases. | BH3-interacting domain death agonist p11; The major proteolytic product p15 BID allows the release of cytochrome c (By similarity). Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2. | 0.999 |
| BAK1 | BMF | ENSP00000363591 | ENSP00000346697 | Bcl-2 homologous antagonist/killer; Plays a role in the mitochondrial apoptosic process. Upon arrival of cell death signals, promotes mitochondrial outer membrane (MOM) permeabilization by oligomerizing to form pores within the MOM. This releases apoptogenic factors into the cytosol, including cytochrome c, promoting the activation of caspase 9 which in turn processes and activates the effector caspases. | Bcl-2-modifying factor; May play a role in apoptosis. Isoform 1 seems to be the main initiator. | 0.924 |
| BAK1 | GART | ENSP00000363591 | ENSP00000371253 | Bcl-2 homologous antagonist/killer; Plays a role in the mitochondrial apoptosic process. Upon arrival of cell death signals, promotes mitochondrial outer membrane (MOM) permeabilization by oligomerizing to form pores within the MOM. This releases apoptogenic factors into the cytosol, including cytochrome c, promoting the activation of caspase 9 which in turn processes and activates the effector caspases. | Trifunctional purine biosynthetic protein adenosine-3; Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase; In the central section; belongs to the AIR synthase family. | 0.401 |
| BAK1 | ST20-MTHFS | ENSP00000363591 | ENSP00000455643 | Bcl-2 homologous antagonist/killer; Plays a role in the mitochondrial apoptosic process. Upon arrival of cell death signals, promotes mitochondrial outer membrane (MOM) permeabilization by oligomerizing to form pores within the MOM. This releases apoptogenic factors into the cytosol, including cytochrome c, promoting the activation of caspase 9 which in turn processes and activates the effector caspases. | 5-formyltetrahydrofolate cyclo-ligase; ST20-MTHFS readthrough; Belongs to the 5-formyltetrahydrofolate cyclo-ligase family. | 0.874 |
| BBC3 | BAK1 | ENSP00000404503 | ENSP00000363591 | Bcl-2-binding component 3, isoforms 3/4; [Isoform 3]: Does not affect cell growth. | Bcl-2 homologous antagonist/killer; Plays a role in the mitochondrial apoptosic process. Upon arrival of cell death signals, promotes mitochondrial outer membrane (MOM) permeabilization by oligomerizing to form pores within the MOM. This releases apoptogenic factors into the cytosol, including cytochrome c, promoting the activation of caspase 9 which in turn processes and activates the effector caspases. | 0.827 |
| BBC3 | BID | ENSP00000404503 | ENSP00000318822 | Bcl-2-binding component 3, isoforms 3/4; [Isoform 3]: Does not affect cell growth. | BH3-interacting domain death agonist p11; The major proteolytic product p15 BID allows the release of cytochrome c (By similarity). Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2. | 0.963 |
| BBC3 | BMF | ENSP00000404503 | ENSP00000346697 | Bcl-2-binding component 3, isoforms 3/4; [Isoform 3]: Does not affect cell growth. | Bcl-2-modifying factor; May play a role in apoptosis. Isoform 1 seems to be the main initiator. | 0.602 |
| BBC3 | ST20-MTHFS | ENSP00000404503 | ENSP00000455643 | Bcl-2-binding component 3, isoforms 3/4; [Isoform 3]: Does not affect cell growth. | 5-formyltetrahydrofolate cyclo-ligase; ST20-MTHFS readthrough; Belongs to the 5-formyltetrahydrofolate cyclo-ligase family. | 0.870 |
| BID | BAK1 | ENSP00000318822 | ENSP00000363591 | BH3-interacting domain death agonist p11; The major proteolytic product p15 BID allows the release of cytochrome c (By similarity). Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2. | Bcl-2 homologous antagonist/killer; Plays a role in the mitochondrial apoptosic process. Upon arrival of cell death signals, promotes mitochondrial outer membrane (MOM) permeabilization by oligomerizing to form pores within the MOM. This releases apoptogenic factors into the cytosol, including cytochrome c, promoting the activation of caspase 9 which in turn processes and activates the effector caspases. | 0.999 |
| BID | BBC3 | ENSP00000318822 | ENSP00000404503 | BH3-interacting domain death agonist p11; The major proteolytic product p15 BID allows the release of cytochrome c (By similarity). Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2. | Bcl-2-binding component 3, isoforms 3/4; [Isoform 3]: Does not affect cell growth. | 0.963 |
| BID | BMF | ENSP00000318822 | ENSP00000346697 | BH3-interacting domain death agonist p11; The major proteolytic product p15 BID allows the release of cytochrome c (By similarity). Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2. | Bcl-2-modifying factor; May play a role in apoptosis. Isoform 1 seems to be the main initiator. | 0.808 |
| BID | ST20-MTHFS | ENSP00000318822 | ENSP00000455643 | BH3-interacting domain death agonist p11; The major proteolytic product p15 BID allows the release of cytochrome c (By similarity). Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2. | 5-formyltetrahydrofolate cyclo-ligase; ST20-MTHFS readthrough; Belongs to the 5-formyltetrahydrofolate cyclo-ligase family. | 0.871 |
| BMF | BAK1 | ENSP00000346697 | ENSP00000363591 | Bcl-2-modifying factor; May play a role in apoptosis. Isoform 1 seems to be the main initiator. | Bcl-2 homologous antagonist/killer; Plays a role in the mitochondrial apoptosic process. Upon arrival of cell death signals, promotes mitochondrial outer membrane (MOM) permeabilization by oligomerizing to form pores within the MOM. This releases apoptogenic factors into the cytosol, including cytochrome c, promoting the activation of caspase 9 which in turn processes and activates the effector caspases. | 0.924 |
| BMF | BBC3 | ENSP00000346697 | ENSP00000404503 | Bcl-2-modifying factor; May play a role in apoptosis. Isoform 1 seems to be the main initiator. | Bcl-2-binding component 3, isoforms 3/4; [Isoform 3]: Does not affect cell growth. | 0.602 |
| BMF | BID | ENSP00000346697 | ENSP00000318822 | Bcl-2-modifying factor; May play a role in apoptosis. Isoform 1 seems to be the main initiator. | BH3-interacting domain death agonist p11; The major proteolytic product p15 BID allows the release of cytochrome c (By similarity). Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2. | 0.808 |
| BMF | ST20-MTHFS | ENSP00000346697 | ENSP00000455643 | Bcl-2-modifying factor; May play a role in apoptosis. Isoform 1 seems to be the main initiator. | 5-formyltetrahydrofolate cyclo-ligase; ST20-MTHFS readthrough; Belongs to the 5-formyltetrahydrofolate cyclo-ligase family. | 0.871 |
| FTCD | GART | ENSP00000380856 | ENSP00000371253 | Formimidoyltetrahydrofolate cyclodeaminase; Folate-dependent enzyme, that displays both transferase and deaminase activity. Serves to channel one-carbon units from formiminoglutamate to the folate pool; In the N-terminal section; belongs to the formiminotransferase family. | Trifunctional purine biosynthetic protein adenosine-3; Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase; In the central section; belongs to the AIR synthase family. | 0.977 |
| FTCD | MTHFD1 | ENSP00000380856 | ENSP00000498336 | Formimidoyltetrahydrofolate cyclodeaminase; Folate-dependent enzyme, that displays both transferase and deaminase activity. Serves to channel one-carbon units from formiminoglutamate to the folate pool; In the N-terminal section; belongs to the formiminotransferase family. | C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed; Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1; In the N-terminal section; belongs to the tetrahydrofolate dehydrogenase/cyclohydrolase family. | 0.978 |
| FTCD | MTHFD2 | ENSP00000380856 | ENSP00000377617 | Formimidoyltetrahydrofolate cyclodeaminase; Folate-dependent enzyme, that displays both transferase and deaminase activity. Serves to channel one-carbon units from formiminoglutamate to the folate pool; In the N-terminal section; belongs to the formiminotransferase family. | Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial; Although its dehydrogenase activity is NAD-specific, it can also utilize NADP at a reduced efficiency. Belongs to the tetrahydrofolate dehydrogenase/cyclohydrolase family. | 0.970 |
